Who is sponsoring NCT07457242?

NCT07457242 is sponsored by Healthspan Biotics.

What drugs are being tested in NCT07457242?

Interventions in NCT07457242: Probiotic Supplementation (Lactobacillus plantarum).

What condition does NCT07457242 study?

NCT07457242 studies Cognition, Multiomics, Microbiome Analysis, Metabolome, Proteome, Metagenome, Probiotics Supplement, Gut-brain Axis, Pilot Study, Adult, Sleep.

Is NCT07457242 still recruiting?

NCT07457242 is currently not yet recruiting. Last updated 9 March 2026.

Last reviewed 2026-03-09 · How we verify

NCT07457242: PROFILE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Probiotic Research: Open-label Functional Intervention and Longitudinal Evaluation in Healthy Adults

Not yet recruiting NA Last updated 9 March 2026

What this trial tests

NA trial testing Probiotic Supplementation (Lactobacillus plantarum) in Cognition in 180 participants. Not yet recruiting.

Timeline

1 July 2026

Primary endpoint
1 July 2027

1 July 2027

Quick facts

Lead sponsor	Healthspan Biotics
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	180
Start date	1 July 2026
Primary completion	1 July 2027
Estimated completion	1 July 2027

Drugs / interventions tested

Probiotic Supplementation (Lactobacillus plantarum) — full drug profile →

Conditions studied

Cognition — all drugs for Cognition →
Multiomics — all drugs for Multiomics →
Microbiome Analysis — all drugs for Microbiome Analysis →
Metabolome — all drugs for Metabolome →

Sponsor

Healthspan Biotics — full company profile →

Who can join

18 and older, any sex, with Cognition or Multiomics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a pre-post, open-label cohort study designed to investigate how a food-grade probiotic supplement affects biological measurements and wellbeing in healthy adults. Participants will take one capsule daily for either 1 month or 6 months. During the study, participants will complete online cognitive tasks and provide blood and stool samples collected during home visits by trained staff. The samples will be analysed to explore changes in gut bacteria and other biological markers. This study aims to understand whether the supplement is well tolerated and whether measurable biological changes occur. The study does not involve any experimental drugs or invasive procedures beyond blood sampling and stool collection, and participants will not be asked to change any current prescribed medications or treatments; with eligibility exclusions applying for recent antibiotics or immunosuppressants. The supplement is being studied for research purposes only and is not intended to diagnose, treat, or prevent disease. Participants will be invited to participate in a follow-up visit to assess long-term effects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Probiotic Supplementation (Lactobacillus plantarum)

Trials testing the same drug.

NCT06863194 — Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial · Phase 1, PHASE2 · recruiting

Other recruiting trials for Cognition

Currently open trials in the same condition.

NCT07401212 — GUTLINK4KIDS Intervention · NA · recruiting
NCT07109505 — Nutrition to Support Postoperative Recovery · NA · recruiting
NCT07334392 — Impact of a Multicomponent Exercise Program on Cognitive and Functional Outcomes in Patients With Mild Cognitive Impairm · NA · recruiting
NCT07236229 — The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis · NA · recruiting
NCT07231497 — Cognitive Strategies in Early Psychosis 1 · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07457242 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Healthspan Biotics
Last refreshed: 9 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07457242.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing